🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cirrhotic cardiomyopathy is associated with increased risk of complications...
Status
Recruiting
Location
Dr. Madhumita Premkumar
Start Date
2023-07-15
Trial ID
NCT06095466
Treatments Being Tested
The purpose of this study was to explore the regulatory and effector T cell...
Status
Completed
Location
Asan Medical Center
Start Date
2021-05-13
Trial ID
NCT07150468
Treatments Being Tested
This protocol pertains specifically to the prospective lung squamous cell c...
Status
Active Not Recruiting
Location
Rocky Mountain Regional VAMC
Start Date
2019-12-06
Trial ID
NCT03881098
Treatments Being Tested
The goal of the study is to examine the ability of resistance or aerobic ex...
Status
Active Not Recruiting
Location
AdventHealth Translational Research Institute
Start Date
2020-11-01
Trial ID
NCT04334343
Treatments Being Tested
This is a prospective, single center translational multiple cohort study to...
Status
Recruiting
Location
University of Turku
Start Date
2022-06-01
Trial ID
NCT06116851
This phase I trial tests the safety, side effects, and best dose of allogen...
Status
Suspended
Location
City of Hope Medical Center
Start Date
2024-02-19
Trial ID
NCT05993611
The goal of this clinical trial is to study whether physical therapy can re...
Status
Recruiting
Location
Clínica INDISA
Start Date
2026-04-20
Trial ID
NCT07017517
Treatments Being Tested
Project Summary: Patients who have a length of stay four or more days in IC...
Status
Completed
Location
Johns Hopkins University
Start Date
2012-07
Trial ID
NCT02214823
Treatments Being Tested
Mitochondrial diseases (MDs) are the most common metabolic disorders. Due t...
Status
Not Yet Recruiting
Location
CHU de Nice - Service de Génétique Médicale
Start Date
2026-06-01
Trial ID
NCT07511608
This phase II trial tests how well tafasitamab and rituximab work for front...
Status
Recruiting
Location
Rutgers Cancer Institute of New Jersey
Start Date
2023-03-23
Trial ID
NCT05786040